Structure Therapeutics (NASDAQ: GPCR) net income
Structure Therapeutics reported a net loss of $141.2m for fiscal 2025; in fiscal 2024 it reported a net loss of $122.5m. Earnings per share were −$0.80.
Structure Therapeutics's best year of the last 4 was fiscal 2022. It reported a loss in 4 of those 4 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$141.2m | — | — | −$0.80 |
| 2024 | −$122.5m | — | — | −$0.78 |
| 2023 | −$89.6m | — | — | −$0.81 |
| 2022 | −$51.3m | — | — | −$5.51 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Structure Therapeutics net income compared with its sector
By net income for its latest fiscal year, Structure Therapeutics ranks 372nd of the 501 US health care companies with a page on Celsmar.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 370th | Inhibrx Biosciences | −$140.1m | −10,773.5% |
| 371st | 4D Molecular Therapeutics | −$140.1m | −164.4% |
| 372nd | Structure Therapeutics | −$141.2m | — |
| 373rd | ADC Therapeutics | −$142.6m | −175.3% |
| 374th | Alector | −$142.9m | −679.2% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Structure Therapeutics
- How much did Structure Therapeutics earn in fiscal 2025?
- Structure Therapeutics reported a net loss of $141.2m for fiscal 2025. In fiscal 2024 it reported a net loss of $122.5m.
- What are the earnings per share of Structure Therapeutics?
- They were −$0.80 in fiscal 2025, compared with −$0.78 in fiscal 2024.
- Where does Structure Therapeutics rank in its sector by net income?
- It ranks 372nd of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Structure Therapeutics come from?
- From the annual report (Form 10-K) that Structure Therapeutics files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Structure Therapeutics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022. More on Structure Therapeutics: the Structure Therapeutics page · annual accounts · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.